Moderna reported for 9 months of 2023

Moderna's GAAP loss for 9 months of 2023 was $4.931 billion, against a profit of $6.897 billion in the prior year. Revenue decreased 3.5 times to $4.037 bln vs. $14.179 bln a year earlier.